These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1. Wu D; Cederbaum AI Alcohol Clin Exp Res; 2001 Apr; 25(4):619-28. PubMed ID: 11329505 [TBL] [Abstract][Full Text] [Related]
4. Nrf2 and antioxidant defense against CYP2E1 toxicity. Cederbaum A Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1223-44. PubMed ID: 19671018 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity. Wu D; Cederbaum A Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321 [TBL] [Abstract][Full Text] [Related]
6. Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1. Wu D; Cederbaum AI Alcohol Clin Exp Res; 1999 Jan; 23(1):67-76. PubMed ID: 10029205 [TBL] [Abstract][Full Text] [Related]
7. Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: role of CYP2E1 and mitochondria. Wu D; Cederbaum AI Hepatology; 2002 Jun; 35(6):1420-30. PubMed ID: 12029627 [TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated expression of Cu/Zn- or Mn-superoxide dismutase protects against CYP2E1-dependent toxicity. Pérez MJ; Cederbaum AI Hepatology; 2003 Nov; 38(5):1146-58. PubMed ID: 14578853 [TBL] [Abstract][Full Text] [Related]
9. The liver-selective nitric oxide donor O2-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (V-PYRRO/NO) protects HepG2 cells against cytochrome P450 2E1-dependent toxicity. Gong P; Cederbaum AI; Nieto N Mol Pharmacol; 2004 Jan; 65(1):130-8. PubMed ID: 14722244 [TBL] [Abstract][Full Text] [Related]
10. Development and properties of HepG2 cells that constitutively express CYP2E1. Wu D; Cederbaum AI Methods Mol Biol; 2008; 447():137-50. PubMed ID: 18369917 [TBL] [Abstract][Full Text] [Related]
11. Synergistic toxicity of iron and arachidonic acid in HepG2 cells overexpressing CYP2E1. Caro AA; Cederbaum AI Mol Pharmacol; 2001 Oct; 60(4):742-52. PubMed ID: 11562436 [TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity. Jimenez-Lopez JM; Cederbaum AI Free Radic Biol Med; 2004 Feb; 36(3):359-70. PubMed ID: 15036355 [TBL] [Abstract][Full Text] [Related]
13. Opposite action of S-adenosyl methionine and its metabolites on CYP2E1-mediated toxicity in pyrazole-induced rat hepatocytes and HepG2 E47 cells. Wu D; Cederbaum AI Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G674-84. PubMed ID: 16306132 [TBL] [Abstract][Full Text] [Related]
14. Decreased protein and mRNA expression of ER stress proteins GRP78 and GRP94 in HepG2 cells over-expressing CYP2E1. Dey A; Kessova IG; Cederbaum AI Arch Biochem Biophys; 2006 Mar; 447(2):155-66. PubMed ID: 16497268 [TBL] [Abstract][Full Text] [Related]
15. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Nieto N; Friedman SL; Cederbaum AI Hepatology; 2002 Jan; 35(1):62-73. PubMed ID: 11786960 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR). Zhuge J Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182 [TBL] [Abstract][Full Text] [Related]
17. Nrf2 and antioxidant defense against CYP2E1 toxicity. Cederbaum AI Subcell Biochem; 2013; 67():105-30. PubMed ID: 23400918 [TBL] [Abstract][Full Text] [Related]
18. Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: effect on transcription factors AP-1 and NF-kappaB. Román J; Colell A; Blasco C; Caballeria J; Parés A; Rodés J; Fernández-Checa JC Hepatology; 1999 Dec; 30(6):1473-80. PubMed ID: 10573527 [TBL] [Abstract][Full Text] [Related]
20. Role of phosphatidylinositol 3-kinase/AKT as a survival pathway against CYP2E1-dependent toxicity. Caro AA; Cederbaum AI J Pharmacol Exp Ther; 2006 Jul; 318(1):360-72. PubMed ID: 16624972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]